```
[Turn 3: Agent V3]
field: Analytical chemistry / chromatography (data quality, measurement reliability, characterization standards, ee determination protocols)
field_rationale: V2 did not preempt Turn 3's default. S0-2 lists substrate scope tables and ee values as primary evidence, and neither V1 nor V2 examined the quality, reliability, or methodological basis of those measurements. Questions about how ee is determined, how absolute configurations are assigned, whether reported yields are isolated or NMR-based, and whether reproducibility data exist are of a fundamentally different kind from both V1's synthetic-scope questions and V2's mechanistic questions.

--- New questions ---

V3-Q1 | P3:Lcol:1* | [REDACTED: substantial verbatim quotation; see Tier 9] [Scheme 3 footnotes] | Scheme 3 mixes isolated yields (standard conditions) with NMR yields (footnote b, 0.1 mmol scale) without systematically indicating which compounds are reported by which method. Compounds 18 and at least some tetrasubstituted-alkene entries appear as NMR yields. The absence of a compound-by-compound disclosure of yield-determination method prevents assessment of whether isolation losses, competing reactions, or scale effects contribute to the reported values. | severity: medium | T1

V3-Q2 | loc: not recoverable | "up to 98% ee" [Abstract]; ee values listed per compound in Scheme 3 | The method for ee determination (chiral stationary-phase HPLC, SFC, NMR with chiral shift reagents, or optical rotation comparison) is not stated in the main text for any compound. Were all 21 products analyzed on the same chiral column under the same conditions, or were multiple chromatographic methods used? Without this disclosure, cross-compound comparisons of ee are methodologically opaque. | severity: medium | T1

V3-Q3 | P3:Rcol:30* | [REDACTED: substantial verbatim quotation; see Tier 9] [Scheme 5] | The absolute configuration of mephenytoin intermediate 29 and the final (R)-mephenytoin are reported, but the basis for the absolute configuration assignment is not stated in the main text (SXRD, VCD, optical rotation comparison with authentic standard, or computational ECD). For a first asymmetric synthesis, this assignment is a primary claim that requires explicit evidentiary support. | severity: high | T2 [paper-grounded inference]

V3-Q4 | P2:Rcol:5* | [REDACTED: substantial verbatim quotation; see Tier 9] [Scheme 2 caption] | Scheme 2 shows approximately 8 condition sets but the paper does not state how many total ligands, solvents, and base combinations were screened in the high-throughput experiment, what the primary screening criterion was (yield, ee, or a composite), or whether conditions were screened at full or reduced scale. Without this, it is not possible to evaluate whether the optimization landscape was adequately sampled. | severity: low | T1

V3-Q5 | loc: not recoverable | Yield and ee values throughout Scheme 3 (21 examples) | No duplicate experiments or standard deviations are reported for any yield or ee value in the main text. Standard practice in asymmetric catalysis (particularly in JACS communications) is to report ee values as averages of ≥2 independent runs, because chiral HPLC measurements and small-scale reactions are subject to weighing, injection, and integration errors. The reproducibility of the claimed ee values (especially near-ceiling values of 97–99% ee) is not established. | severity: medium | T2 [paper-grounded inference]

V3-Q6 | P2:Lcol:1* | "5 mol % Pd(OAc)₂, L1 (10 mol %)" [Table 1, entry 5 conditions] | The enantiomeric purity of the commercially obtained chiral ligand L1 is not stated. For phosphoramidite ligands derived from BINOL, the ee of the ligand itself sets an upper bound on the product ee via the Horeau principle. If L1 is ≥99.5% ee, this does not materially affect interpretation, but if it is lower (e.g., 97–98% ee from a commercial source), the intrinsic ceiling for product ee is reduced. This is not disclosed. | severity: medium | T2 [paper-grounded inference]

V3-Q7 | P2:Rcol:10* | [REDACTED: substantial verbatim quotation; see Tier 9] [Scheme 3, footnote for compound 6] | The gram-scale yield (31%) is reported without specifying whether this is an isolated yield after chromatographic purification, whether starting material was recovered, or what purity was confirmed. The 2.5-fold decrease from 0.5 mmol scale (78%) is unexplained. No characterization data or purity analysis for the gram-scale product are provided in the main text. | severity: medium | T1

V3-Q8 | P2:Lcol:1* | "40 °C, 24 h" [Table 1, all entries] | The 24-hour reaction time is reported uniformly for the standard conditions, but no time-course experiments or conversion-vs-time data are reported. It is not stated whether 24 h corresponds to complete conversion of the electrophile, a point of maximal ee:conversion trade-off, or an arbitrary endpoint. For substrates run at different temperatures (75 °C or 23 °C), the rationale for the same reaction time is also not discussed. | severity: low | T1

--- Overlaps with V1/V2 ---

V3-OV1 | overlaps_with: V1-Q9 | severity_V3: medium | note: From an analytical chemistry perspective, the 5-entry Table 1 represents a highly selected subset of optimization data; the absence of a full design-of-experiments or systematic condition matrix makes it impossible to assess whether the reported optimum is a local or global maximum in the parameter space.

V3-OV2 | overlaps_with: V1-Q13 | severity_V3: high | note: The gram-scale yield of 31% vs 78% at 0.5 mmol represents a significant scale-dependent discrepancy that requires analytical justification — including confirmation that the gram-scale product purity is equivalent and that the ee was measured under validated conditions.

V3-OV3 | overlaps_with: V1-Q3 | severity_V3: high | note: Compound 18 is reported as 99% NMR yield, 63% ee — mixing NMR (crude, in-situ) yield with isolated ee from chiral HPLC represents a methodological inconsistency; the NMR yield overestimates synthetic utility compared to isolated yield, and the 63% ee at 75 °C warrants confirmation by duplicate run.

V3-OV4 | overlaps_with: V2-Q3 | severity_V3: medium | note: The claim that higher Pd loading erodes ee (due to racemic 26 converting to 5) would require quantitative monitoring of both 5 and 26 over time by chiral HPLC to validate; no such time-resolved data are presented.
```

---

> **Tier 8 redaction notice**: This file is a redacted copy of the corresponding Tier 3 / Tier 9 output. Verbatim source-paper quotations have been replaced by `[REDACTED: see source paper §<loc>; full text retained in Tier 9 reviewer-only deposit]` markers, preserving location references and our own analytical content. Bibliographic fields (title, authors, journal, year, DOI), analytical labels (`evidence_chain:` with B-/U-/A-/C- internal IDs), short technical terms, and our own analytical text are not redacted. The redaction was applied by `scripts/redact_for_tier8.py` and, for this version, by `scripts/build_paperA_R1_public.py` with `scripts/redact_source_ngram_runs.py` (scripts of the project repository; they are not deposited).
